The Challenge: To track the novel treatments’ (including gene and RNA therapies) landscape in the Hemophilia space.
The LucidQuest team worked to fully characterize the rapidly evolving hemophilia landscape (including capturing intelligence on novel tech and treatment platforms entering the space) in order to identify potential opportunities for differentiation for our client.
The Action: Primary intelligence collection during conferences and KOL interviews for deep insights.
By attending several medical conferences and engaging in interviews with key opinion leaders (KOLs), the LucidQuest team gained deep insights into competitor strategies and the latest advancements in hemophilia treatments.
The Result: The client used our insights to develop branding and strategic positioning that were aligned with the evolving market reality.
The insights gathered were instrumental in informing the client’s brand planning process, equipping them with a nuanced understanding of the competitive environment and enabling strategic positioning in the hemophilia space.
#hemophilia #CGT #CellandGeneTherapy #CompetitiveIntelligence #KOLStrategy #casestudy #ourwork